Get the Stockscreener App
3.1584
7.20%
-0.245
Impact BioMedical, Inc. stock is traded at $3.1584, with a volume of 28,706.
It is down -7.20% in the last 24 hours and down -52.69% over the past month.
See More
Previous Close:
$3.4034
Open:
$3.17
24h Volume:
28,706
Relative Volume:
2.18
Market Cap:
$26.98M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-23.15%
1M Performance:
-52.69%
6M Performance:
-62.97%
1Y Performance:
-58.50%
1-Day Range:
$0.00
$0.00
1-Week Range:
$2.62
$4.46
52-Week Range:
$2.62
$10.47
Impact BioMedical, Inc. Stock (IBO) Company Profile
Name
Impact BioMedical, Inc.
Sector
Industry
Phone
-
Address
-
Compare IBO vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IBO
Impact BioMedical, Inc.
|
3.1584 | 26.98M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Impact BioMedical, Inc. Stock (IBO) Latest News
Stock splits calendar for: - Yahoo Finance Australia
Form 4 Impact Biomedical Inc For: 24 September By Investing.com - Investing.com India
10% Owner Inc. Dss, Sells 906 Shares of Impact BioMedical Inc (I - GuruFocus
Form 4 Impact Biomedical Inc For: 24 September By Investing.com - Investing.com Canada
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com South Africa
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock - Investing.com
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com India
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com Canada
DSS Inc., 10% owner, sells $1,686 in Impact Biomedical stock By Investing.com - Investing.com UK
Across three days, DSS sold 906 Impact Biomedical (IBO) shares at prices from $0.55 to $7.0587. - Stock Titan
Impact Biomedical executes 1-for-12.62 reverse stock split ahead of Zoar Ltd. merger - Pluang
Impact BioMedical (IBO) moves toward Zoar merger vote - Stock Titan
DSS Says Zoar Files Form F-4 for Impact Biomedical Combination - citybiz.co
Impact Biomedical files F-4 for business combination - Investing.com
Impact Biomedical Inc. Announces Filing of F-4 Registration Statement for Proposed Business Combination with Zoar Limited - Quiver Quantitative
DSS Announces Filing of Form F-4 by Zoar Limited in Connection with Proposed Business Combination with Impact Biomedical - Quiver Quantitative
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited - Yahoo Finance
Impact Biomedical Inc Announces Filing of Form F-4 - GlobeNewswire
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited) - Yahoo Finance
Impact Biomedical files F-4 for business combination By Investing.com - Investing.com UK
Impact Biomedical's proposed merger could create a company developing and supplying drug ingredients - Stock Titan
A proposed deal involving Impact Biomedical reaches U.S. regulators. It is not approved yet. - Stock Titan
IBO: Impact BioMedical Inc. Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Impact Biomedical approves 1-for-12.62 reverse stock split ahead of proposed Zoar merger - TradingView
Impact BioMedical (NYSE: IBO) shrinks share count ahead of proposed Zoar merger - Stock Titan
Impact Biomedical expects shares to fall from about 107.8 million to 8.54 million - Stock Titan
Impact Biomedical corrects merger exchange ratio, sets reverse stock split - Investing.com
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 - GlobeNewswire
Impact Biomedical Announces 1-for-12.62 Reverse Stock Split Ahead of Proposed Zoar Limited Merger - Moomoo
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited) - Yahoo Finance
Impact BioMedical approves 1-for-12.62 reverse stock split - Investing.com
Impact BioMedical Announces 1-for-12.62 Reverse Stock Split Ahead of Proposed Zoar Merger - Quiver Quantitative
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for - GlobeNewswire
About 108 million shares are expected to become 8.5 million as Impact BioMedical pursues a proposed merger. - Stock Titan
Impact BioMedical to Effect 1-for-12.62 Reverse Stock Split - marketscreener.com
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.) - Yahoo Finance
Impact BioMedical, Inc. (IBO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
IBO - Finviz
Rosen Law Firm Encourages Impact Biomedical Inc. Investors to Inquire About Securities Class Action Investigation – IBO - Business Wire
Impact BioMedical Inc. Reports Going Concern Audit Opinion - GlobeNewswire
Impact BioMedical Inc. Reports "Going Concern" Qualification in Annual 10-K Audit Opinion and Plans Merger with Dr. Ashley's Ltd. - Quiver Quantitative
Impact Biomedical (IBO) 10K Form and Latest SEC Filings 2026 - MarketBeat
Grady Jason sells Impact Biomedical (IBO) stock worth $32,505 - Investing.com
Impact BioMedical Advances Dr Ashleys Combination With Amended Terms, Holder Support and DSS Funding - TradingView
Impact BioMedical, Inc. Stock (IBO) Financials Data
There is no financial data for Impact BioMedical, Inc. (IBO). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Impact BioMedical, Inc. Stock (IBO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Macko Todd D | Chief Financial Officer |
Mar 27 '26 |
Sale |
0.56 |
43,400 |
24,369 |
155,122 |
| Macko Todd D | Chief Financial Officer |
Mar 25 '26 |
Sale |
0.60 |
1,600 |
961 |
198,122 |
| Grady Jason | Director |
Mar 23 '26 |
Sale |
0.65 |
50,000 |
32,505 |
250,182 |
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):